CVD and depression are a two-way street, capable of inflicting considerable damage on one another. So how do heart patients protect their mental health after a life-threatening event like MI?

The American Society for Radiation Oncology (ASTRO) is championing bipartisan legislation introduced Wednesday, June 5, that would reduce prior authorization practices found to delay patient access to necessary cancer treatments.

Active-duty Army personnel in the U.S. have poorer cardiovascular health than the larger civilian population, researchers have found—especially when it comes to blood pressure.

Patients with end-stage renal disease (ESRD) face higher risks of in-hospital mortality and bleeding with transcatheter aortic valve replacement (TAVR) than patients who aren’t dialysis-dependent, researchers report in the Journal of the American College of Cardiology.

Arizona-based R3 Stem Cell, LLC is under fire this week after the FDA sent the company an untitled, three-page letter detailing significant shortcomings in their process.

Despite a sizable financial disadvantage, ST-segment elevation MI (STEMI) patients who could be treated effectively in an intensive or non-intensive care unit fare better in the ICU, according to research published June 4 in The BMJ.

Biotronik is targeting a minimum of 40% female enrollment for its newest project, a large-scale prospective study of sex differences in patients with non-ischemic cardiomyopathy (NICM) and an implanted cardiovascular device.

Heart patients prone to emotionally triggered atrial fibrillation are less likely to experience an arrhythmia if they’re taking beta-blockers, according to a June 3 study published in Heart Rhythm.